1 | preliminary program june | | | | | | | 1 | 0.63% |
2 | click here to find | | | | | | | 1 | 0.63% |
3 | from the national heart | | | | | | | 1 | 0.63% |
4 | 1r13hl168860 from the national | | | | | | | 1 | 0.63% |
5 | by 1r13hl168860 from the | | | | | | | 1 | 0.63% |
6 | part by 1r13hl168860 from | | | | | | | 1 | 0.63% |
7 | in part by 1r13hl168860 | | | | | | | 1 | 0.63% |
8 | possible in part by | | | | | | | 1 | 0.63% |
9 | made possible in part | | | | | | | 1 | 0.63% |
10 | was made possible in | | | | | | | 1 | 0.63% |
11 | funding for this conference | | | | | | | 1 | 0.63% |
12 | more funding for this | | | | | | | 1 | 0.63% |
13 | out more funding for | | | | | | | 1 | 0.63% |
14 | find out more funding | | | | | | | 1 | 0.63% |
15 | to find out more | | | | | | | 1 | 0.63% |
16 | here to find out | | | | | | | 1 | 0.63% |
17 | – click here to | | | | | | | 1 | 0.63% |
18 | and blood institute nhlbi | | | | | | | 1 | 0.63% |
19 | 2027 – click here | | | | | | | 1 | 0.63% |
20 | forum 2027 – click | | | | | | | 1 | 0.63% |
21 | request for proposals lymphatic | | | | | | | 1 | 0.63% |
22 | disease request for proposals | | | | | | | 1 | 0.63% |
23 | lymphatic disease request for | | | | | | | 1 | 0.63% |
24 | in lymphatic disease request | | | | | | | 1 | 0.63% |
25 | gaps in lymphatic disease | | | | | | | 1 | 0.63% |
26 | program june 12 | | | | | | | 1 | 0.63% |
27 | issues and gaps in | | | | | | | 1 | 0.63% |
28 | session 5 – unsolved | | | | | | | 1 | 0.63% |
29 | plenary session 5 – | | | | | | | 1 | 0.63% |
30 | diseases plenary session 5 | | | | | | | 1 | 0.63% |
31 | human diseases plenary session | | | | | | | 1 | 0.63% |
32 | in human diseases plenary | | | | | | | 1 | 0.63% |
33 | the national heart lung | | | | | | | 1 | 0.63% |
34 | blood institute nhlbi the | | | | | | | 1 | 0.63% |
35 | lymphatic dysfunction in human | | | | | | | 1 | 0.63% |
36 | policies of the department | | | | | | | 1 | 0.63% |
37 | endorsement by the us | | | | | | | 1 | 0.63% |
38 | imply endorsement by the | | | | | | | 1 | 0.63% |
39 | organizations imply endorsement by | | | | | | | 1 | 0.63% |
40 | or organizations imply endorsement | | | | | | | 1 | 0.63% |